Hall, JG, Agranovich, O, Pontén, E, van Bosse, HJP. Summary of the 2nd international symposium on arthrogryposis, St. Petersburg, Russia, September 17–19, 2014. Am J Med Genet A. 2015;167(6):1193–35.Google Scholar

Lowry, RB, Sibbald, B, Bedard, T, Hall, JG. Prevalence of multiple congenital contractures including arthrogryposis multiplex congenita in Alberta, Canada, and a strategy for classification and coding. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1057–61.CrossRefGoogle Scholar

Hall, JG, Aldinger, KA, Tanaka, KI. Amyoplasia revisited. Am J Med Genet A. 2014;164(3):700–30.CrossRefGoogle Scholar

Chen, H. Arthrogryposis. Emedicine Journal, March 2, 2015. Available at: http://emedicine.medscape.com/article/941917-overview Accessed March 31, 2019.Google Scholar

Hall, JG. Arthrogryposis (multiple congenital contractures): diagnostic approach to etiology, classification, genetics, and general principles. Eur J Med Genet. 2014;57(8):464–72.CrossRefGoogle ScholarPubMed

Bamshad, M, Van Heest, AE, Pleasure, D. Arthrogryposis: a review and update. J Bone Joint Surg Am. 2009;91 Suppl 4:40–6.CrossRefGoogle ScholarPubMed

Fassier, A, Wicart, P, Dubousset, J, Seringe, R. Arthrogryposis multiplex congenita. Long-term follow-up from birth until skeletal maturity. J Child Orthop. 2009;3(5):383–90.CrossRefGoogle ScholarPubMed

Hall, JG. Oligohydramnios sequence revisited in relationship to arthrogryposis, with distinctive skin changes. Am J Med Genet A. 2014;164A(11):2775–92.Google ScholarPubMed

Hall, JG. Pena-Shokeir phenotype (Fetal akinesia deformation sequence) revisited. Birth Defects Res A Clin Mol Teratol. 2009;85(8):677–94.Google Scholar

Roscam Abbing, PJ, Hageman, G, Willemse, J. CT-scanning of skeletal muscle in arthrogryposis multiplex congenita. Brain Dev. 1985;7(5):484–91.CrossRefGoogle ScholarPubMed

Filges, I, Hall, JG. Failure to identify antenatal multiple congenital contractures and fetal akinesia – proposal of guidelines to improve diagnosis: Disorders of fetal movement – proposal of guidelines. Prenat Diagn. 2013;33(1):61–74.Google Scholar

Vuopala, K, Leisti, J, Herva, R. Lethal arthrogryposis in Finland – a clinico-pathological study of 83 cases during thirteen years. Neuropediatrics. 1994;25(6):308–15.Google Scholar

Konya, MN, Elmas, M, Özdemir, Ç. Analysis of musculoskeletal dysmorphic abnormalities of 20 fetuses. Eklem Hastalik Cerrahisi. 2017;28(2):114–20.CrossRefGoogle ScholarPubMed

Dillon, ER, Bjornson, KF, Jaffe, KM, Hall, JG, Song, K. Ambulatory activity in youth with arthrogryposis: a cohort study. J Pediatr Orthop. 2009 Mar;29(2):214–17.CrossRefGoogle ScholarPubMed

Sells, JM, Jaffe, KM, Hall, JG. Amyoplasia, the most common type of arthrogryposis: the potential for good outcome. Pediatrics. 1996;97(2):225–31.Google Scholar

Bevan, WP, Hall, JG, Bamshad, M, Staheli, LT, Jaffe, KM, Song, K. Arthrogryposis multiplex congenita (amyoplasia): an orthopaedic perspective. J Pediatr Orthop. 2007;27(5):594–600.Google Scholar

Ma, L, Yu, X. Arthrogryposis multiplex congenita: classification, diagnosis, perioperative care, and anesthesia. Front Med. 2017;11(1):48–52.CrossRefGoogle ScholarPubMed

Verhaart, IEC, Robertson, A, Wilson, IJ, Aartsma-Rus, A, Cameron, S, Jones, CC, Cook, SF, Lochmüller, H. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy – a literature review. Orphanet J Rare Dis 2017;12:124–39.CrossRefGoogle ScholarPubMed

Peeters, K, Chamova, T, Jordanova, A. Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies. Brain 2014; 137:2879–96.CrossRefGoogle ScholarPubMed

Arnold, WD, Kassar, D, Kissel, JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015 51(2):157–67.Google Scholar

Harding, BN. In: Developmental Neuropathology, 2nd edition, Adle-Biassette, H, Harding, BN, and Golden, JA, eds., John Wiley & Sons, 2018, pp. 469–75.Google Scholar

Prior, TW and Finanger, E. Spinal muscular atrophy. GeneReviews. Last updated December 22, 2016. www.ncbi.nlm.nih.gov/books/NBK1352/.Google Scholar

Darras, BT. Spinal muscular atrophies. Pediatr Clin North Am. 2015 62(3):743–66.Google Scholar

Finkel, RS, Mercuri, E, Darras, BT, Connolly, AM, Kuntz, NL, Kirschner, J, Chiriboga, CA, Saito, K, Servais, L, Tizzano, E, Topaloglu, H, Tulinius, M, Montes, J, Glanzman, AM, Bishop, K, Zhong, ZJ, Gheuens, S, Bennett, CF, Schneider, E, Farwell, W, De Vivo, DC, ENDEAR Study Group.Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017 377(18):1723–32.Google Scholar

Lowes, LP, Alfano, LN, Arnold, WD, Shell, R, Prior, TW, McColly, M, Lehman, KJ, Church, K, Sproule, DM, Nagendran, S, Menier, M, Feltner, DE, Wells, C, Kissel, JT, Al-Zaidy, S, Mendell, J. Impact of age and motor function in a phase 1/2a study of infants with SMA type 1 receiving single-dose gene replacement therapy. Pediatr Neurol. 2019;98:39–45.CrossRefGoogle Scholar

Rossor, AM, Tomaselli, PJ, Reilly, MM. Recent advances in the genetic neuropathies. Curr Opin Neurol. 2016;29(5):537–48.Google Scholar

Dowling, JJ, Gonorazky HD, , Cohn, RD, Campbell, C. Treating pediatric neuromuscular disorders: the future is now. Am J Med Genet A. 2018;176(4):804–41.CrossRefGoogle ScholarPubMed

Arnold, WD, Isfort, M, Roggenbuck, J, Hoyle, JC. The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management. Appl Clin Genet. 2015;8:235–43.Google Scholar

Bird, TD. Charcot-Marie-Tooth (CMT) hereditary neuropathy overview. GeneReviews. (Initial posting: September 28, 1998; Last revision: January 24, 2019.) www.ncbi.nlm.nih.gov/books/NBK1358/.Google Scholar

Boerkoel, CF, Takashima, H, Stankiewicz, P, Garcia, CA, Leber, SM, Rhee-Morris, L, et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet. 2001;68(2):325–33.Google Scholar

Katona, I, Weis, J. Diseases of the peripheral nerves. Handb Clin Neurol. 2017;145:453–74.Google Scholar

Charnas, L, Trapp, B, Griffin, J. Congenital absence of peripheral myelin: abnormal Schwann cell development causes lethal arthrogryposis multiplex congenita. Neurology. 1988;38(6):966–74.Google Scholar

Lebo, RV. Prenatal diagnosis of Charcot-Marie-Tooth disease. Prenat Diagn. 1998;18(2):169–72.Google Scholar

Dello Russo, C, Padula, F, Di Giacomo, G, Mesoraca, A, Gabrielli, I, Bizzoco, D, Giorlandino, C. A new approach for next generation sequencing in prenatal diagnosis applied to a case of Charcot-Marie-Tooth syndrome. Prenat Diagn. 2015;35(10):1018–21.Google Scholar

Amato, AA, Russel, JA. Neuromuscular Disorders, 2nd edition. McGraw-Hill Education, New York; 2016.Google Scholar

Azmaipairashvili, Z, Riddle, EC, Scavina, M, Kumar, SJ. Correction of cavovarus foot deformity in Charcot-Marie-Tooth disease. J Pediatr Orthop. 2005;25(3):360–5.Google Scholar

Ghamdi, M, Armstrong, DL, Miller, G. Congenital hypomyelinating neuropathy: a reversible case. Pediatr Neurol. 1997;16(1):71–3.CrossRefGoogle ScholarPubMed

Levy, BK, Fenton, GA, Loaiza, S, Hayat, GR. Unexpected recovery in a newborn with severe hypomyelinating neuropathy. Pediatr Neurol. 1997;16(3):245–8.Google Scholar

Phillips, JP, Warner, LE, Lupski, JR, Garg, BP. Congenital hypomyelinating neuropathy: two patients with long-term follow-up. Pediatr Neurol. 1999;20(3):226–32.Google Scholar

Cruz, PMR, Palace, J, Beeson, D. The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes. Int J Mol Sci 2018; 19(6): 1677.Google Scholar

Abicht, A, Müller, J, Lochmüller, H. Congenital myasthenic syndromes. In: Adam, MP, Ardinger, HH, Pagon, RA, et al., editors., GeneReviews® [Internet]. Seattle: University of Washington; 1993–2019 (last updated July 14, 2016).Google Scholar

GeneTable of Neuromuscular Diseases; www.musclegenetable.frGoogle Scholar

Engel, AG, Shen, X-M, Selcen, D, Sine, SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2016;14(4):420–34.Google Scholar

Engel, AG, Shen X-M, Selcen D. The unfolding landscape of the congenital myasthenic syndromes. Ann N Y Acad Sci. 2018;1413(1):25–34.Google Scholar

Finsterer, J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019 14(1):57.CrossRefGoogle ScholarPubMed

Szelinger S, Krate J, Ramsey K, Strom SP, Shieh PB, Lee H, Belnap N, Balak C, Siniard AL, Russell M, Richholt R, Both M, Claasen AM, Schrauwen I, Nelson SF, Huentelman MJ, Craig DW, Yang SP, Moore SA, Sivakumar K, Narayanan V, Rangasamy S; UCLA Clinical Genomics Center. Congenital myasthenic syndrome caused by a frameshift insertion mutation in GFPT1. Neurol Genet. 2020;6(4):e468.CrossRefGoogle Scholar

Bönnemann, CG, Wang, CH, Quijano-Roy, S, Deconinck, N, Bertini, E, Ferreiro, A, Muntoni, F, Sewry, C, Béroud, C, Mathews, KD, Moore, SA, Bellini, J, Rutkowski, A, North, KN, on behalf of Members of the International Standard of Care Committee for Congenital Muscular Dystrophies.Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 2014:24(4):289–311.Google Scholar

Dowling, JJ, Gonorazky, HD, Cohn, RD, Campbell, C. Treating pediatric muscular disorders: the future is now. Am J Med Genet 2018:176:804–41.Google Scholar

GeneTable of Neuromuscular Diseases; www.musclegenetable.fr/Google Scholar

Leung, DG. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol 2017 July;264(7):1320–33.CrossRefGoogle ScholarPubMed

Amato, AA, Russell, JA. Neuromuscular Disorders, 2nd ed. New York: McGraw Hill Education, 2016.Google Scholar

Quijano-Roy, S, Sparks, SE, Rutkowski, A. LAMA2-related muscular dystrophy. GeneReviews. June 7, 2012. www.ncbi.nlm.nih.gov/books/NBK97333/.Google Scholar

Sellick, GS, Longman, C, Brockington, M, Mahjneh, I, Sagi, L, Bushby, K, Topaloğlu, H, Muntoni, F, Houlston, RS. Localisation of merosin-positive congenital muscular dystrophy to chromosome 4p16.3. Hum Genet. 2005 117(2–3):207–12.Google Scholar

Yurchenco, PD, McKee, KK, Reinhard, JR, Rüegg, MA. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. Matrix Biol. 2018;71–2:174–87.Google Scholar

Yoshida-Moriguchi, T, Campbell, KP. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology. 2015; 25(7):702–13.CrossRefGoogle ScholarPubMed

Bouchet-Séraphin, C, Vuillaumier-Barrot, S, Seta, N. Dystroglycanopathies: about numerous genes involved in glycosylation of one single glycoprotein. J Neuromuscul Dis. 2015;2(1):27–38.Google Scholar

Devisme, L, Bouchet, C, Gonzalès, M, Alanio, E, Bazin, A, Bessières, B, Bigi, N, Blanchet, P, Bonneau, D, Bonnières, M, Bucourt, M, Carles, D, Clarisse, B, Delahaye, S, Fallet-Bianco, C, Figarella-Branger, D, Gaillard, D, Gasser, B, Delezoide, AL, Guimiot, F, Joubert, M, Laurent, N, Laquerrière, A, Liprandi, A, Loget, P, Marcorelles, P, Martinovic, J, Menez, F, Patrier, S, Pelluard, F, Perez, MJ, Rouleau, C, Triau, S, Attié-Bitach, T, Vuillaumier-Barrot, S, Seta N, Encha-Razavi F. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies.Brain. 2012;135(Pt 2):469–82.Google Scholar

Godfrey, C, Foley, AR, Clement, E, Muntoni, F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev. 2011;21(3):278–85.CrossRefGoogle ScholarPubMed

Willer, T, Lee, H, Lommel, M, Yoshida-Moriguchi, T, de Bernabe, DB, Venzke, D, Cirak, S, Schachter, H, Vajsar, J, Voit, T, Muntoni, F, Loder, AS, Dobyns, WB, Winder, TL, Strahl, S, Mathews, KD, Nelson, SF, Moore, SA, Campbell, KP. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet. 2012;44(5):575–80.Google Scholar

Wallace, SE, Conta, JH, Winder, TL, Willer, T, Eskuri, JM, Haas, R, Patterson, K, Campbell, KP, Moore, SA, Gospe, SM Jr. A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscul Disord. 2014;24(4):312–20.Google Scholar

Chang, W, Winder, TL, LeDuc, CA, Simpson, LL, Millar, WS, Dungan, J, Ginsberg, N, Plaga, S, Moore, SA, Chung, WK. Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn. 2009;29(6):560–9.Google ScholarPubMed

Lampe, AK, Flanigan, KM, Bushby, KM, Hicks, D. Collagen type VI-related disorders. GeneReviews, last updated August 9, 2012. www.ncbi.nlm.nih.gov/books/NBK1503/.Google Scholar

Bönnemann, CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011;7(7):379–90.Google Scholar

Yonekawa, T, Nishino, I. Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s). J Neurol Neurosurg Psychiatry. 2015;86(3):280–7.CrossRefGoogle ScholarPubMed

Komaki, H, Hayashi, YK, Tsuburaya, R, Sugie, K, Kato, M, Nagai, T, Imataka, G, Suzuki, S, Saitoh, S, Asahina, N, Honke, K, Higuchi, Y, Sakuma, H, Saito, Y, Nakagawa, E, Sugai, K, Sasaki, M, Nonaka, I, Nishino, I. Inflammatory changes in infantile-onset LMNA-associated myopathy. Neuromuscul Disord. 2011;21(8):563–8.Google Scholar

Quijano-Roy, S, Mbieleu, B, Bönnemann, CG, Jeannet, PY, Colomer, J, Clarke, NF, Cuisset, JM, Roper, H, De Meirleir, L, D’Amico, A, Ben Yaou, R, Nascimento, A, Barois, A, Demay, L, Bertini, E, Ferreiro, A, Sewry, CA, Romero, NB, Ryan, M, Muntoni, F, Guicheney, P, Richard, P, Bonne, G, Estournet, B. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol. 2008;64(2):177–86.Google Scholar

Cassandrini, et al. Congenital myopathies: clinical phenotypes and new diagnostic tools. Ital J Pediatr 2017:43:101.Google Scholar

Massalska, D, et al. Prenatal diagnosis of congenital myopathies and muscular dystrophies. Clin Genet 2016;90:199–210.Google Scholar

GeneTable of Neuromuscular Diseases; www.musclegenetable.fr/Google Scholar

Jungbluth, H, Treves, S, Zorzato, F, Sarkozy, A, Ochala, J, Sewry, C, Phadke, R, Gautel, M, Muntoni, F. Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction. Nat Rev Neurol. 2018;14(3):151–67.Google Scholar

Malicdan, MCV and Nishino, I. Central core disease. GeneReviews. Last updated December 4, 2014. www.ncbi.nlm.nih.gov/books/NBK1391/.Google Scholar

Pelin, K and Wallgren-Pettersson, C. Update on the genetics of congenital myopathies. Sem Ped Neurol 29:12–22, 2019.Google Scholar

North, KN and Ryan, MM. Nemaline myopathy. GeneReviews. Last updated June 11, 2015. www.ncbi.nlm.nih.gov/books/NBK1288/.Google Scholar

Dowling, JJ, Lawlor, MW, and Das, S. X-linked myotubular myopathy. GeneReviews. Last updated August 23, 2018. www.ncbi.nlm.nih.gov/books/NBK1116/?term=MTM1.Google Scholar

Lawlor, MW, Beggs, AH, Buj-Bello, A, Childers, MK, Dowling, JJ, James, ES, Meng, H, Moore, SA, Prasad, S, Schoser, B, Sewry, CA. Skeletal muscle pathology in X-linked myotubular myopathy: review with cross-species comparisons. J Neuropathol Exp Neurol. 2016;75(2):102–10.Google Scholar

Leung, DG. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol 2017;264:1320–33.Google Scholar

McNeil, SM, et al. Congenital inflammatory myopathy: a demonstrative case and proposed diagnostic classification. Muscle Nerve 2002;25(2):259–64.Google Scholar

Andre, LM, et al. Skeletal muscle myogenesis in DM. Frontiers in Neurology 2018;9:1–24.Google Scholar

Ho, G, et al. Congenital and childhood myotonic dystrophy: current aspects of disease and future directions. World J Clin Pediatr 2015;4(4):66–80.Google Scholar

Shevell, M, et al. Congenital inflammatory myopathy. Neurology 1990;40(7):111–14.Google Scholar

Leung, DG. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol 2017;264:1320–33.Google Scholar